glp-1-agonist-comparison-table 
Med Ed 101
JULY 26, 2020
Glucagon-like peptide-1 receptor agonists, or GLP-1s, are a highly appealing, newer class of medications for the treatment of type 2 diabetes. Through their activity at the GLP-1 receptor, they slow gastric emptying and decrease glucagon secretion.
PQA
DECEMBER 7, 2023
1 In the US, 34.2 million adults have diabetes, and 1 in 5 are unaware of their diagnosis.2 5, 6 It also imitates a hormone naturally produced in the gut, glucagon-like peptide-1, thereby reducing appetite and signaling the body to feel full, as well as prompting the stomach to empty at a slower pace.
Expert insights. Personalized for you.
40 
Let's personalize your content